Regenerative Medicine

Regenerative medicine represents a rapidly evolving field in cardiac research, aiming to restore heart function by repairing or reversing tissue damage rather than merely managing symptoms. Cardiovascular diseases (CVDs) remain the leading cause of morbidity and mortality worldwide, highlighting the urgent need for innovative therapeutic strategies. Our lab is focused on harnessing the body’s intrinsic repair mechanisms to develop effective, accessible treatments for heart disease. Inspired by the remarkable regenerative capacity of the neonatal heart—an ability that is lost shortly after birth—we explore novel approaches to reactivate these pathways in the adult heart. A key area of our research involves repurposing Copaxone, an FDA-approved immunomodulatory drug, to promote cardiac repair. By modulating the immune environment and enhancing tissue regeneration, Copaxone shows promise as a unique therapeutic candidate that could transform the way we treat myocardial infarction and heart failure.